Chronic Inflammatory Diseases and Endothelial Dysfunction

Abstract

Chronic inflammatory diseases are associated with increases in cardiovascular diseases (CVD) and subclinical atherosclerosis as well as early-stage endothelial dysfunction screening using the FMD method (Flow Mediated Dilation). This phenomenon, referred to as accelerated pathological remodeling of arterial wall, could be attributed to traditional risk factors associated with atherosclerosis. Several new non-invasive techniques have been used to study arterial wall's structural and functional alterations.These techniques (based of Radio Frequency, RF) allow for an assessment of artery age through calculations of intima-media thickness (RF-QIMT), pulse wave rate (RF-QAS) and endothelial dysfunction degree (FMD). The inflammatory and autoimmune diseases should now be considered as new cardiovascular risk factors, result of the major consequences of oxidative stress and RAS (Renin Angiotensin System) imbalance associated with the deleterious effect of known risk factors that lead to the alteration of the arterial wall. Inflammation plays a key role in all stages of the formation of vascular lesions maintained and exacerbated by the risk factors. The consequence of chronic inflammation is endothelial dysfunction that sets in and we can define it as an integrated marker of the damage to arterial walls by classic risk factors. The atherosclerosis, which develops among these patients, is the main cause for cardiovascular morbi-mortality and uncontrolled chronic biological inflammation, which quickly favors endothelial dysfunction. These inflammatory and autoimmune diseases should now be considered as new cardiovascular risk factors.

Endothelial progenitor cells: Are they displaying a function in autoimmune disorders?

“…Inflammation and complement depositions in the vessel wall are likely to contribute to vascular stiffness. Based on biopsy findings, also inflammation in the myocardium and small vessels may contribute to premature CVD in ARDs (cardiac ischemia and heart failure) (Castellon and Bogdanova, 2016) There is an enormous need for an improved CVD prevention in ARDs. Studies examining the effect of DMARDs/biologics on vascular inflammation and CV risk are warranted.…”

Exosomes Derived From Low‐Intensity Pulsed Ultrasound‐Treated Dendritic Cells Suppress Tumor Necrosis Factor–Induced Endothelial Inflammation

“…Atherosclerosis is associated with progressive narrowing of the artery lumen, causing major adverse cardiovascular events (MACEs), including myocardial infarction and stroke . Chronic inflammation diseases of the vessel wall are associated with increases in atherosclerosis and early‐stage endothelial dysfunction . Dendritic cells (DCs) are specialized antigen‐presenting cells, positioned within the immune system to bridge innate and adaptive immunity .…”

Limb Remote Ischemic Conditioning Promotes Myelination by Upregulating PTEN/Akt/mTOR Signaling Activities after Chronic Cerebral Hypoperfusion

“…The pathogenic mechanisms responsible for hypoperfusion-mediated white matter lesions include blood-brain barrier (BBB) leakage [9, 10], inflammation [11, 12] and oxidative stress [13], which collectively lead to apoptosis of oligodendrocyte cells and demyelination. Demyelination or loss of sheath is a critical feature of white matter lesions induced by cerebral hypoperfusion [14].…”